🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Taiyen Biotech Co., Ltd. (TPE:1737)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.25
-0.35 (-1.18%)
Nov 20, 2026, 1:30 PM CST

Taiyen Biotech Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,3561,3491,5511,4451,5291,726
Short-Term Investments
11.9211.4140.314.24-1.06
Trading Asset Securities
379.98384.99346.32390.61353.18353.54
Cash & Short-Term Investments
1,7481,7461,9381,8401,8822,080
Cash Growth
4.48%-9.92%5.35%-2.27%-9.52%10.15%
Accounts Receivable
442.98524.03498.3663.23650.28757.6
Other Receivables
-9.686.2323.4332.787.19
Receivables
442.98533.71504.53686.66683.06764.79
Inventory
407.09376.81427.32394.74407.37395.02
Other Current Assets
86.199.9457.64105.27121.26154.52
Total Current Assets
2,6842,7562,9273,0263,0943,395
Property, Plant & Equipment
4,0804,1194,0233,9053,7133,564
Long-Term Investments
40.9940.9840.9733.96--
Other Intangible Assets
11.7710.1711.716.415.348.53
Long-Term Deferred Tax Assets
57.0357.0363.6581.972.1287.22
Other Long-Term Assets
1,3011,2791,3151,2661,3271,413
Total Assets
8,1758,2638,3818,3208,2128,468

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
381.81329.32419.51384.5399.06485.3
Short-Term Debt
77869810020287.53
Current Portion of Long-Term Debt
0.565.5666.9515.318.654.29
Current Portion of Leases
6.067.418.767.269.2710.76
Current Income Taxes Payable
8.6852.0243.3666.2942.1779.75
Current Unearned Revenue
68.7670.19109.7698.03102.2379.02
Other Current Liabilities
369.57409.4418.81429.62344.67358.74
Total Current Liabilities
912.43959.891,1651,101926.051,305
Long-Term Debt
--5.5672.568.9353.08
Long-Term Leases
23.1926.5625.9325.0928.5936.33
Long-Term Unearned Revenue
271.95284.66297.72307.19320.05332.92
Pension & Post-Retirement Benefits
3.173.1737.6894.0462.39108.81
Long-Term Deferred Tax Liabilities
35.335.339.4434.3834.2334.08
Other Long-Term Liabilities
159.74139.22142.08136.68109.5283.67
Total Liabilities
1,4061,4491,7141,7711,5501,954

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
2,0002,0002,0002,0002,0002,000
Additional Paid-In Capital
2,4912,4912,5022,5022,5022,502
Retained Earnings
2,2792,3252,1651,9932,0221,862
Comprehensive Income & Other
-0.71-2.39-2.63-3.38-2.99-2.16
Total Common Equity
6,7696,8146,6646,4916,5216,361
Minority Interest
--3.5357.6140.69152.2
Shareholders' Equity
6,7696,8146,6686,5496,6626,513
Total Liabilities & Equity
8,1758,2638,3818,3208,2128,468

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
106.8125.52205.2220.17135.44391.98
Net Cash (Debt)
1,6411,6201,7331,6191,7471,688
Net Cash Growth
6.54%-6.49%7.00%-7.29%3.46%0.42%
Net Cash Per Share
8.208.078.648.088.718.42
Filing Date Shares Outstanding
198.65200200200200200
Total Common Shares Outstanding
198.65200200200200200
Working Capital
1,7711,7961,7621,9252,1682,089
Book Value Per Share
34.0834.0733.3232.4632.6131.81
Tangible Book Value
6,7576,8046,6526,4856,5166,353
Tangible Book Value Per Share
34.0234.0233.2632.4232.5831.76
Land
-1,8161,8161,8161,8161,736
Buildings
-1,6541,5681,4231,3541,322
Machinery
-3,6403,5073,0042,8372,844
Construction In Progress
-79.36186.56632.49440.46323.04